Catalyst Wire Dossier Catalyst Wire Dossier

AEROVANT AER 001 Inhalation Powder

· Aerovance, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AEROVANT AER 001 Inhalation Powder, covering 2011-01-27 to 2011-01-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL [Phase 2]

See pricing